Global Robotic Capsule Endoscopes (RCEs) Market Growth 2025-2031

The global Robotic Capsule Endoscopes (RCEs) market size is predicted to grow from US$ 499 million in 2025 to US$ 1440 million in 2031; it is expected to grow at a CAGR of 19.3% from 2025 to 2031.

Robotic Capsule Endoscopes (RCEs) are innovative medical devices designed for gastrointestinal (GI) examinations. These are small, swallowable capsule-shaped devices equipped with cameras, lights, and sensors. Once ingested, the capsule naturally moves through the digestive tract, capturing high-resolution images and video data in real-time, which are wirelessly transmitted to external devices for analysis by doctors. Compared to traditional endoscopy, RCEs offer a non-invasive, comfortable, and convenient experience while accessing regions like the small intestine that are hard to reach using conventional methods. Advanced RCEs may also include micro-mechanical components for precise navigation and intervention, further enhancing diagnostic and therapeutic outcomes.

Robotic capsule endoscopes have gained increasing recognition as a revolutionary tool for diagnosing gastrointestinal diseases. Compared to traditional endoscopy, their non-invasive and convenient features significantly enhance patient acceptance. The market is currently driven by leading medical device companies and tech developers, focusing on advancements in image quality, navigation precision, and real-time data transmission. As the technology matures, robotic capsule endoscopes have transitioned from experimental phases to commercial applications, spanning hospitals, clinics, and remote healthcare settings.The market for robotic capsule endoscopes is expected to experience sustained growth, driven by rising global rates of gastrointestinal diseases, expanding demand for healthcare services, and the integration of artificial intelligence. Enhancements such as automated diagnostic capabilities and smart algorithms are likely to improve diagnostic efficiency and accuracy. Furthermore, as manufacturing costs decrease and technology becomes more accessible, these devices may increasingly penetrate primary healthcare facilities, accelerating their adoption.Key drivers include the aging population, ongoing medical innovation, and the growing demand for comfort and precision in healthcare. However, the industry faces challenges, such as high R&D and production costs, a lack of standardized technology, and regulatory or insurance-related hurdles in some regions. While these factors may slow market expansion, breakthroughs in technology and supportive policies are expected to mitigate these barriers over time.

LP Information, Inc. (LPI) ' newest research report, the “Robotic Capsule Endoscopes (RCEs) Industry Forecast” looks at past sales and reviews total world Robotic Capsule Endoscopes (RCEs) sales in 2024, providing a comprehensive analysis by region and market sector of projected Robotic Capsule Endoscopes (RCEs) sales for 2025 through 2031. With Robotic Capsule Endoscopes (RCEs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Robotic Capsule Endoscopes (RCEs) industry.

This Insight Report provides a comprehensive analysis of the global Robotic Capsule Endoscopes (RCEs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Robotic Capsule Endoscopes (RCEs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Robotic Capsule Endoscopes (RCEs) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Robotic Capsule Endoscopes (RCEs) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Robotic Capsule Endoscopes (RCEs).

This report presents a comprehensive overview, market shares, and growth opportunities of Robotic Capsule Endoscopes (RCEs) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Capsule Colonoscopy

Capsule Gastroscopy

Segmentation by Application:

Physical Examination Center

Hospital

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Chongqing Jinshan

Medtronic

Olympus

IntroMedic

BioCam

Check-Cap

Shenzhen Jifu Medical Technology

Ankon Technologies

Shangxian Minimal Invasive

Hangzhou Hitron Medical Equipment

Beijing Richen-Force

Guangzhou Side Medical Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Robotic Capsule Endoscopes (RCEs) market?

What factors are driving Robotic Capsule Endoscopes (RCEs) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Robotic Capsule Endoscopes (RCEs) market opportunities vary by end market size?

How does Robotic Capsule Endoscopes (RCEs) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.